Skip to main content
Erschienen in: Diabetologia 7/2005

01.07.2005 | Article

Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation

verfasst von: R. L. Hull, K. Kodama, K. M. Utzschneider, D. B. Carr, R. L. Prigeon, S. E. Kahn

Erschienen in: Diabetologia | Ausgabe 7/2005

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Increased dietary fat intake is associated with obesity and insulin resistance, but studies have shown that the subsequent increase in insulin release is not appropriate for this obesity-induced insulin resistance. We therefore sought to determine whether the impaired beta cell adaptation is due to inadequate expansion of the beta cell population or to a lack of an adaptive increase in insulin release.

Methods

Male mice were fed diets containing increasing amounts of fat (15, 30 or 45% of energy intake) for 1 year, after which islet morphology and secretory function were assessed.

Results

Increased dietary fat intake was associated with a progressive increase in body weight (p<0.001). Fractional beta cell area (total beta cell area/section area) was increased with increasing dietary fat (1.36±0.39, 2.46±0.40 and 4.93±1.05%, p<0.001), due to beta cell hyperplasia, and was positively and highly correlated with body weight (r 2=0.68, p<0.005). In contrast, insulin release following i.p. glucose did not increase with increasing dietary fat (118±32, 108±47 and 488±200 pmol/l per mmol/l, p=0.07) and did not correlate with body weight (r 2=0.11). When this response was examined relative to fractional beta cell area (insulin release/fractional beta cell area), it did not increase but rather tended to decrease with increasing dietary fat (157±55, 43±13 and 97±53 [pmol/l per mmol/l]/%, p=0.06) and did not correlate with body weight (r 2=0.02).

Conclusions/interpretation

Long-term fat feeding is associated with an increase in the beta cell population but an inadequate functional adaptation. Thus, a functional rather than a morphological abnormality appears to underlie dietary-fat-induced beta cell dysfunction.
Literatur
1.
Zurück zum Zitat Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP (2001) The continuing epidemic of obesity and diabetes in the United States. JAMA 286:1195–1200CrossRefPubMed Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP (2001) The continuing epidemic of obesity and diabetes in the United States. JAMA 286:1195–1200CrossRefPubMed
2.
Zurück zum Zitat Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359CrossRefPubMed Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359CrossRefPubMed
3.
Zurück zum Zitat Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed
4.
Zurück zum Zitat Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672PubMed Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672PubMed
5.
Zurück zum Zitat Westermark P (1972) Quantitative studies on amyloid in the islets of Langerhans. Ups J Med Sci 77:91–94PubMed Westermark P (1972) Quantitative studies on amyloid in the islets of Langerhans. Ups J Med Sci 77:91–94PubMed
6.
Zurück zum Zitat Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU (1985) Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4:110–125PubMed Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU (1985) Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4:110–125PubMed
7.
Zurück zum Zitat Clark A, Wells CA, Buley ID et al (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis—quantitative changes in the pancreas in type-2 diabetes. Diab Res Clin Exp 9:151–159 Clark A, Wells CA, Buley ID et al (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis—quantitative changes in the pancreas in type-2 diabetes. Diab Res Clin Exp 9:151–159
8.
Zurück zum Zitat Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMed Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMed
9.
Zurück zum Zitat Reaven GM (1988) Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMed Reaven GM (1988) Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMed
10.
Zurück zum Zitat Pi-Sunyer FX (1993) Medical hazards of obesity. Ann Intern Med 119:655–660PubMed Pi-Sunyer FX (1993) Medical hazards of obesity. Ann Intern Med 119:655–660PubMed
11.
Zurück zum Zitat Marshall JA, Hoag S, Shetterly S, Hamman RF (1994) Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 17:50–56 Marshall JA, Hoag S, Shetterly S, Hamman RF (1994) Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 17:50–56
12.
Zurück zum Zitat Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW (1986) Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 251:E576–E583PubMed Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW (1986) Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 251:E576–E583PubMed
13.
Zurück zum Zitat Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW (1991) Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40:280–289PubMed Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW (1991) Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40:280–289PubMed
14.
Zurück zum Zitat Rocchini AP, Marker P, Cervenka T (1997) Time course of insulin resistance associated with feeding dogs a high-fat diet. Am J Physiol 272:E147–E154PubMed Rocchini AP, Marker P, Cervenka T (1997) Time course of insulin resistance associated with feeding dogs a high-fat diet. Am J Physiol 272:E147–E154PubMed
15.
Zurück zum Zitat Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Porte D Jr, Schwartz MW (1999) Reduced beta-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. Am J Physiol 277:E659–E667PubMed Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Porte D Jr, Schwartz MW (1999) Reduced beta-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. Am J Physiol 277:E659–E667PubMed
16.
Zurück zum Zitat Garcia-Ocana A, Takane KK, Syed MA, Philbrick WM, Vasavada RC, Stewart AF (2000) Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem 275:1226–1232CrossRefPubMed Garcia-Ocana A, Takane KK, Syed MA, Philbrick WM, Vasavada RC, Stewart AF (2000) Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem 275:1226–1232CrossRefPubMed
17.
Zurück zum Zitat Ludwig DS, Tritos NA, Mastaitis JW et al (2001) Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 107:379–386PubMed Ludwig DS, Tritos NA, Mastaitis JW et al (2001) Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 107:379–386PubMed
18.
Zurück zum Zitat Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA (2001) Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 108:1631–1638CrossRefPubMed Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA (2001) Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 108:1631–1638CrossRefPubMed
19.
Zurück zum Zitat Butler AE, Janson J, Soeller WC, Butler PC (2003) Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52:2304–2314PubMed Butler AE, Janson J, Soeller WC, Butler PC (2003) Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52:2304–2314PubMed
20.
Zurück zum Zitat Bock T, Pakkenberg B, Buschard K (2003) Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 52:1716–1722PubMed Bock T, Pakkenberg B, Buschard K (2003) Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 52:1716–1722PubMed
21.
Zurück zum Zitat Hull RL, Andrikopoulos S, Verchere CB et al (2003) Increased dietary fat promotes islet amyloid formation and β-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52:372–379PubMed Hull RL, Andrikopoulos S, Verchere CB et al (2003) Increased dietary fat promotes islet amyloid formation and β-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52:372–379PubMed
22.
Zurück zum Zitat Morgan DR, Lazarow A (1963) Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes 12:115–126 Morgan DR, Lazarow A (1963) Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes 12:115–126
23.
Zurück zum Zitat Andrikopoulos S, Verchere CB, Terauchi Y, Kadowaki T, Kahn SE (2000) Beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. Diabetes 49:2056–2062PubMed Andrikopoulos S, Verchere CB, Terauchi Y, Kadowaki T, Kahn SE (2000) Beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. Diabetes 49:2056–2062PubMed
24.
Zurück zum Zitat Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311–322CrossRefPubMed Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182:311–322CrossRefPubMed
25.
Zurück zum Zitat Olney JW, Tenkova T, Dikranian K, Qin YQ, Labruyere J, Ikonomidou C (2002) Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain. Brain Res Dev Brain Res 133:115–126CrossRefPubMed Olney JW, Tenkova T, Dikranian K, Qin YQ, Labruyere J, Ikonomidou C (2002) Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain. Brain Res Dev Brain Res 133:115–126CrossRefPubMed
26.
Zurück zum Zitat Wang F, Hull RL, Vidal J, Cnop M, Kahn SE (2001) Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. Diabetes 50:2514–2520PubMed Wang F, Hull RL, Vidal J, Cnop M, Kahn SE (2001) Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. Diabetes 50:2514–2520PubMed
27.
Zurück zum Zitat Jonckheere AR (1954) A distribution-free k-sample test against ordered alternatives. Biometrika 41:133–145 Jonckheere AR (1954) A distribution-free k-sample test against ordered alternatives. Biometrika 41:133–145
28.
Zurück zum Zitat Bonner-Weir S, Deery D, Leahy JL, Weir GC (1989) Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes 38:49–53PubMed Bonner-Weir S, Deery D, Leahy JL, Weir GC (1989) Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes 38:49–53PubMed
29.
Zurück zum Zitat Steil GM, Trivedi N, Jonas JC et al (2001) Adaptation of beta-cell mass to substrate oversupply: enhanced function with normal gene expression. Am J Physiol Endocrinol Metab 280:E788–E796PubMed Steil GM, Trivedi N, Jonas JC et al (2001) Adaptation of beta-cell mass to substrate oversupply: enhanced function with normal gene expression. Am J Physiol Endocrinol Metab 280:E788–E796PubMed
30.
Zurück zum Zitat Woerner CA (1939) Studies on the islands of Langerhans after continuous injection of dextrose. Anat Rec 71:22–57 Woerner CA (1939) Studies on the islands of Langerhans after continuous injection of dextrose. Anat Rec 71:22–57
31.
Zurück zum Zitat Ahren B, Simonsson E, Scheurink AJ, Mulder H, Myrsen U, Sundler F (1997) Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 46:97–106CrossRefPubMed Ahren B, Simonsson E, Scheurink AJ, Mulder H, Myrsen U, Sundler F (1997) Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 46:97–106CrossRefPubMed
32.
Zurück zum Zitat Ahren B, Scheurink AJ (1998) Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur J Endocrinol 139:461–467CrossRefPubMed Ahren B, Scheurink AJ (1998) Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur J Endocrinol 139:461–467CrossRefPubMed
33.
Zurück zum Zitat Mulder H, Martensson H, Sundler F, Ahrén B (2000) Differential changes in islet amyloid polypeptide (amylin) and insulin mRNA expression after high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 49:1518–1522CrossRefPubMed Mulder H, Martensson H, Sundler F, Ahrén B (2000) Differential changes in islet amyloid polypeptide (amylin) and insulin mRNA expression after high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 49:1518–1522CrossRefPubMed
34.
Zurück zum Zitat Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B (2002) Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 282:E834–E842PubMed Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B (2002) Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 282:E834–E842PubMed
35.
Zurück zum Zitat Pacini G, Thomaseth K, Ahrén B (2001) Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. Am J Physiol Endocrinol Metab 281:E693–E703PubMed Pacini G, Thomaseth K, Ahrén B (2001) Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. Am J Physiol Endocrinol Metab 281:E693–E703PubMed
36.
Zurück zum Zitat Ahren B, Pacini G (2002) Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. Am J Physiol Endocrinol Metab 283:E738–E744PubMed Ahren B, Pacini G (2002) Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. Am J Physiol Endocrinol Metab 283:E738–E744PubMed
37.
Zurück zum Zitat Lee SK, Opara EC, Surwit RS, Feinglos MN, Akwari OE (1995) Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice. Pancreas 11:206–211PubMed Lee SK, Opara EC, Surwit RS, Feinglos MN, Akwari OE (1995) Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice. Pancreas 11:206–211PubMed
38.
Zurück zum Zitat Zhou YP, Grill VE (1994) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870–876PubMed Zhou YP, Grill VE (1994) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870–876PubMed
39.
Zurück zum Zitat Bollheimer LC, Skelly RH, Chester MW, McGarry JD, Rhodes CJ (1998) Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101:1094–1101PubMed Bollheimer LC, Skelly RH, Chester MW, McGarry JD, Rhodes CJ (1998) Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101:1094–1101PubMed
40.
Zurück zum Zitat Bjorklund A, Grill V (1999) Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets. Diabetes 48:1409–1414PubMed Bjorklund A, Grill V (1999) Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets. Diabetes 48:1409–1414PubMed
41.
Zurück zum Zitat Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF (1999) Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276:E1055–E1066PubMed Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF (1999) Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276:E1055–E1066PubMed
42.
Zurück zum Zitat Mason TM, Goh T, Tchipashvili V et al (1999) Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 48:524–530PubMed Mason TM, Goh T, Tchipashvili V et al (1999) Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 48:524–530PubMed
43.
Zurück zum Zitat Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte–beta-cell relationships. Proc Natl Acad Sci U S A 91:10878–10882PubMed Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte–beta-cell relationships. Proc Natl Acad Sci U S A 91:10878–10882PubMed
44.
Zurück zum Zitat Kelpe CL, Johnson LM, Poitout V (2002) Increasing triglyceride synthesis inhibits glucose-induced insulin secretion in isolated rat islets of Langerhans: a study using adenoviral expression of diacylglycerol acyltransferase. Endocrinology 143:3326–3332CrossRefPubMed Kelpe CL, Johnson LM, Poitout V (2002) Increasing triglyceride synthesis inhibits glucose-induced insulin secretion in isolated rat islets of Langerhans: a study using adenoviral expression of diacylglycerol acyltransferase. Endocrinology 143:3326–3332CrossRefPubMed
45.
Zurück zum Zitat Mulder H, Holst LS, Svensson H et al (1999) Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes 48:228–232PubMed Mulder H, Holst LS, Svensson H et al (1999) Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes 48:228–232PubMed
46.
Zurück zum Zitat Surwit RS, Wang S, Petro AE et al (1998) Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc Natl Acad Sci U S A 95:4061–4065CrossRefPubMed Surwit RS, Wang S, Petro AE et al (1998) Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc Natl Acad Sci U S A 95:4061–4065CrossRefPubMed
47.
Zurück zum Zitat Chan CB, De Leo D, Joseph JW et al (2001) Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 50:1302–1310PubMed Chan CB, De Leo D, Joseph JW et al (2001) Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 50:1302–1310PubMed
48.
Zurück zum Zitat Winzell MS, Svensson H, Enerback S et al (2003) Pancreatic beta-cell lipotoxicity induced by overexpression of hormone-sensitive lipase. Diabetes 52:2057–2065PubMed Winzell MS, Svensson H, Enerback S et al (2003) Pancreatic beta-cell lipotoxicity induced by overexpression of hormone-sensitive lipase. Diabetes 52:2057–2065PubMed
49.
Zurück zum Zitat Shimabukuro M, Zhou YT, Lee Y, Unger RH (1998) Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem 273:3547–3550CrossRefPubMed Shimabukuro M, Zhou YT, Lee Y, Unger RH (1998) Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem 273:3547–3550CrossRefPubMed
50.
Zurück zum Zitat Mulder H, Sorhede-Winzell M, Contreras JA et al (2003) Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. J Biol Chem 278:36380–36388CrossRefPubMed Mulder H, Sorhede-Winzell M, Contreras JA et al (2003) Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. J Biol Chem 278:36380–36388CrossRefPubMed
51.
Zurück zum Zitat Joseph JW, Koshkin V, Zhang CY et al (2002) Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 51:3211–3219PubMed Joseph JW, Koshkin V, Zhang CY et al (2002) Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 51:3211–3219PubMed
52.
Zurück zum Zitat Hosokawa YA, Hosokawa H, Chen C, Leahy JL (1996) Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagon-like peptide-1 (7–37). J Clin Invest 97:180–186PubMed Hosokawa YA, Hosokawa H, Chen C, Leahy JL (1996) Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagon-like peptide-1 (7–37). J Clin Invest 97:180–186PubMed
53.
Zurück zum Zitat Ward WK, Wallum BJ, Beard JC, Taborsky GJ Jr, Porte D Jr (1988) Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes 37:723–729PubMed Ward WK, Wallum BJ, Beard JC, Taborsky GJ Jr, Porte D Jr (1988) Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes 37:723–729PubMed
Metadaten
Titel
Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation
verfasst von
R. L. Hull
K. Kodama
K. M. Utzschneider
D. B. Carr
R. L. Prigeon
S. E. Kahn
Publikationsdatum
01.07.2005
Erschienen in
Diabetologia / Ausgabe 7/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1772-9

Weitere Artikel der Ausgabe 7/2005

Diabetologia 7/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.